Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; none of the 41 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Building on the declining trend of malaria in Ethiopia, the Federal Ministry of Health aims to eliminate malaria by 2030. As Plasmodium falciparum and Plasmodium vivax are co-endemic in Ethiopia, the use of primaquine is indicated for both transmission interruption and radical cure, respectively. However, the limited knowledge of the local prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency and its associated variants has hindered the use of primaquine. METHODS: Some 11,138 dried blood spot (DBS) samples were collected in 2011 as part of a national, household Malaria Indicator Survey, a multi-stage nationally representative survey of all malaria-endemic areas of Ethiopia. A randomly selected sub-set of 1414 DBS samples was successfully genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Considering the geographical position and ethnic mix of the country, three common variants: G6PD*A (A376G), G6PD*A- (G202A) and Mediterranean (C563T) were investigated. RESULTS: Of the 1998 randomly selected individuals, 1429 (71.5%) DBS samples were genotyped and merged to the database, of which 53.5% were from females. G6PD*A (A376G) was the only genotype detected. No sample was positive for either G6PD*A- (G202A) or Mediterranean (C563T) variants. The prevalence of G6PD*A (A376G) was 8.9% [95% confidence interval (CI) 6.7-11.2] ranging from 12.2% in the Southern Nations, Nationalities and Peoples' (95% CI 5.7-18.7) to none in Dire Dawa/Harari Region. CONCLUSION: The common G6PD*A- (G202A) or Mediterranean (C563T) variants were not observed in this nationwide study. The observed G6PD*A (A376G) mutation has little or no clinical significance. These findings supported the adoption of primaquine for P. falciparum transmission interruption and radical cure of P. vivax in Ethiopia. As the presence of other clinically important, less common variants cannot be ruled out, the implementation of radical cure will be accompanied by active haematological and adverse events monitoring in Ethiopia.
Overview
CoChat Summary
TL;DR
In a nationally representative 2011 Ethiopian Malaria Indicator Survey sample, the only detected G6PD variant among three screened was G6PD*A (A376G), at 8.9% (95% CI 6.7–11.2), while G6PD*A− (G202A) and Mediterranean (C563T) were absent. These findings supported Ethiopia’s adoption of primaquine for P. falciparum transmission interruption and P. vivax radical cure without prior G6PD testing, with active safety monitoring.
Key findings
- G6PD*A (A376G) was the only genotype detected: 8.9% (95% CI 6.7–11.2) of analysed samples; 57.8% (75/130) of mutations were in females.
- No sample was positive for G6PD*A− (G202A) or Mediterranean (C563T).
- Regional weighted prevalence of G6PD*A (A376G) ranged from 12.2% (95% CI 5.7–18.7) in Southern Nations, Nationalities and Peoples’ to 0 in Dire Dawa/Harari; regional variation was not statistically significant (P = 0.278).
- Prevalence was 9.2% (95% CI 6.7–11.8) below 2000 m and 7.9% (95% CI 2.4–13.4) at 2000–2500 m (P = 0.403); no spatial clustering was observed.
Methods
- Cross-sectional analysis of dried blood spot (DBS) samples from the 2011 national Malaria Indicator Survey, a multi-stage, nationally representative household survey of malaria-endemic areas of Ethiopia; 11,138 DBS were collected, and 1998 individuals were randomly selected.
- Of selected samples, 1429 were genotyped and merged to the database, with 1414 valid genotype results; 53.5% were from females, and mean age was 14.3 years (range 1–89).
- PCR–RFLP was used to screen for G6PD*A (A376G), G6PD*A− (G202A), and Mediterranean (C563T); weighted prevalence estimates were calculated by region, with 10% of samples genotyped at CDC for quality assurance.
Limitations
- The paper states a large sample loss (29.2%), mainly because corresponding DBS could not be located, though it suggests little or no systematic bias from this random loss.
- The study tested only three common variants among hundreds of known G6PD variants, so it cannot definitively conclude that all clinically relevant G6PD-deficient variants are absent in Ethiopians (e.g., G6PD Rehovot), especially in regions with very few samples.
- The paper states it reports genotypic, not phenotypic, prevalence; no positive controls were used for the Mediterranean (C563T) mutation, and further studies are needed to identify variants underlying phenotypic deficiency reported in some groups.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 0 Not valid · 19 Not checked · 15 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No spatial clustering was observed for the G6PD*A (A376G) mutation (Fig. 2b) which was similar to the spatial distribution of all samples selected (Fig. 2a).”
§ Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The study showed that the G6PD*A (A376G) mutation was the only mutation found in 8.9% (95% confidence interval (CI) 6.7–11.2) of the analysed samples.”
- Also stated in: § Discussion · plain
“In this nationally representative study, 8.9% of the samples were noted to carry the G6PD*A (A376G) variant; the clinically relevant variants of G6PD*A− (G202A) and Mediterranean (C563T) were not observed.”
§ Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Discussion · plain
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ethiopia, especially the highlands, may represent a lower risk location for the use of primaquine in the radical cure for P. vivax malaria without G6PD testing.”
§ Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study > Conclusion
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
None of the sources cited for this claim have been checked yet.
In the paper
“The widespread use of primaquine has been limited due to its potential to induce haemolytic anaemia in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals.”
§ Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study > Background
What the sources say
- Not checked yetcites [3] Beutler E, Duparc S, G6PD Deficiency Working Group. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77:779–89. source
- Not checked yetcites [4] Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, et al. Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J. 2013;12:418. source
- Not checked yetcites [5] Beutler E. G6PD deficiency. Blood. 1994;84:3613–36. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In Ethiopia, there is limited information about the occurrence and distribution of G6PD deficiency [7].”
§ Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study > Background
What the sources say
- Not checked yetcites [7] Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133–201. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
3 more claims
Create a free account to see all 34 claims and to verify the 39 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, the African G6PD allele (G202A) was not identified in the nationwide house survey.”
From Pooled prevalence of Glucose-6-phosphate dehydrogenase deficiency among malaria patients in Ethiopia: a systematic review and meta-analysis (2026) · cites this paper as [25]
In the citing paper
“Although the nationwide household survey study was published in 2018, the data were collected 6 years before its publication.”
From Pooled prevalence of Glucose-6-phosphate dehydrogenase deficiency among malaria patients in Ethiopia: a systematic review and meta-analysis (2026) · cites this paper as [25]
In the citing paper
“In this study, the clinically significant variant (G6PDA − (G202A)) was identified among four endemic regions (Amhara, Oromia, Benishangul Gumuz and Gambela) [36].”
From Pooled prevalence of Glucose-6-phosphate dehydrogenase deficiency among malaria patients in Ethiopia: a systematic review and meta-analysis (2026) · cites this paper as [36]
In the citing paper
“A previous study conducted in a 2011 household survey identified only the G6PD*A (A376G) mutant variant [25].”
From Pooled prevalence of Glucose-6-phosphate dehydrogenase deficiency among malaria patients in Ethiopia: a systematic review and meta-analysis (2026) · cites this paper as [25]
In the citing paper
“Furthermore, a genetic analysis of 2000 samples from the 2011 Malaria Indicator Survey (MIS) found no A- or Mediterranean variants [13].”
From Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study (2025) · cites this paper as [13]
Citations
Cites
Beutler, E. (1994) · Blood · doi:10.1182/blood.v84.11.3613.bloodjournal84113613 · Cited by 731
Ruwende, C., Khoo, S. C., Snow, R. W., Yates, S. N. R., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C. E. M., Gilbert, S. C., Peschu, N., et al. (1995) · Nature · doi:10.1038/376246a0 · Cited by 595
The IMPROV Study Group (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1276-2 · Cited by 277
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
Beutler, E., Vulliamy, T., & Luzzatto, L. (1996) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.1996.0008 · Cited by 258
Howes, R. E., Battle, K. E., Satyagraha, A. W., Baird, J. K., & Hay, S. I. (2013) · Advances in Parasitology · doi:10.1016/b978-0-12-407826-0.00004-7 · Cited by 220
Glucose-6-Phosphate Dehydrogenase Deficiency and Antimalarial Drug Development
Beutler, E., Duparc, S., & _, _. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.779 · Cited by 215
The Ecology of Health and Disease in Ethiopia
Kloos, H., & Zein, Z. A. (2019) · Routledge eBooks · doi:10.4324/9780429310232 · Cited by 208
Hematologically Important Mutations: Glucose-6-phosphate Dehydrogenase
Beutler, E., & Vulliamy, T. J. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0490 · Cited by 141
Spatial distribution of G6PD deficiency variants across malaria-endemic regions
Howes, R. E., Dewi, M., Piel, F. B., Monteiro, W. M., Battle, K. E., Messina, J. P., Sakuntabhai, A., Satyagraha, A. W., Williams, T. N., Baird, J. K., et al. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-418 · Cited by 135
Nucleotide Variability at G6pd and the Signature of Malarial Selection in Humans
Saunders, M. A., Hammer, M. F., & Nachman, M. W. (2002) · Genetics · doi:10.1093/genetics/162.4.1849 · Cited by 123
Cited by
Zhou, Y., & Lauschke, V. M. (2021) · Human Genetics · doi:10.1007/s00439-021-02385-x · Cited by 98
Gari, T., & Lindtjørn, B. (2018) · Malaria Journal · doi:10.1186/s12936-018-2607-8 · Cited by 63
Alemayehu, A. (2023) · Parasite Epidemiology and Control · doi:10.1016/j.parepi.2023.e00295 · Cited by 46
Multiplex serology demonstrate cumulative prevalence and spatial distribution of malaria in Ethiopia
Assefa, A., Ahmed, A. A., Deressa, W. A., Sime, H., Mohammed, H., Kebede, A., Solomon, H., Teka, H., Gurrala, K., Matei, B., et al. (2019) · Malaria Journal · doi:10.1186/s12936-019-2874-z · Cited by 43
Self-citationLo, E., Zhong, D., Raya, B., Pestana, K., Koepfli, C., Lee, M.-C., Yewhalaw, D., & Yan, G. (2019) · Malaria Journal · doi:10.1186/s12936-019-2981-x · Cited by 23
Metadata
- Authors
- Assefa, A., Ali, A., Deressa, W., Tsegaye, W., Abebe, G., Sime, H., Kebede, A., Jima, D., Kassa, M., Abreha, T., Teka, H., Solomon, H., Malone, J., Shi, Y. P., Zhou, Z., Reithinger, R., & Hwang, J.
- Affiliations
- Ethiopian Public Health Institute (ET)
- Addis Ababa University (ET)
- Columbia University (US)
- United States Agency for International Development (US)
- Federal Ministry of Health (ET)
- Centers for Disease Control and Prevention (US)
- RTI International (US)
- Corresponding author
- Assefa, Ashenafi
- ORCID
- Venue
- Malaria Journal
- Published
- 2018-10-26
- Volume
- 17
- Issue
- 1
- Pages
- 388-388
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC6204031
- OpenAlex
- W2898115386
- Cited by
- 34
- References
- 27
- Citations by year
- 2026: 9 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 9 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- United States Agency for International Development
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- glucose-6-phosphate dehydrogenase deficiency, G6PD variants, primaquine, Plasmodium falciparum, Plasmodium vivax, malaria elimination, radical cure, transmission interruption, G6PD prevalence, Ethiopia
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Alleles, Child, Child, Preschool, Ethiopia, Female, Genotype, Glucosephosphate Dehydrogenase Deficiency, Humans, Infant, Male, Middle Aged, Prevalence, Malaria, Falciparum, Malaria, Vivax, Endemic Diseases, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. https://app.cochat.ai/papers/10.1186/s12936-018-2538-4
- The paper
- Assefa, A., Ali, A., Deressa, W., Tsegaye, W., Abebe, G., Sime, H., Kebede, A., Jima, D., Kassa, M., Abreha, T., Teka, H., Solomon, H., Malone, J., Shi, Y. P., Zhou, Z., Reithinger, R., & Hwang, J. (2018). Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. Malaria Journal. https://doi.org/10.1186/s12936-018-2538-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.